Off-Label Prescribing Was Common, Novo Nordisk Tells Jury
By Ben Adlin · October 28, 2025, 10:30 PM EDT
A whistleblower suing drugmaker Novo Nordisk for allegedly defrauding Washington state's Medicaid system acknowledged from the witness stand Tuesday that she previously prescribed hemophilia drugs for off-label use in her own...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login